DMD Digital Health Connections Group Inc (APTOF) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.69 (+0.90%), Market cap $0.00B, 52-week low–high $0.80 ~ $1.85.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloid malignancies, such as acute myeloid leukemia and the higher risk myelodysplastic syndromes. It has license agreements with National Cancer Institute for the clinical development of tuspetinib; and Hanmi Pharmaceutical Co Ltd. to research, develop, and commercialize tuspetinib. The company was forme
Financial statements, price targets, institutional (13F) holdings and related news for DMD Digital Health Connections Group Inc are updated in real time on BlackAll Trade.
DMD Digital Health Connections Group Inc trades at $1.69 (+0.90%). Real-time quotes and charts are available on BlackAll Trade.
DMD Digital Health Connections Group Inc has a market cap of about $0.00B.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's cli